Diamond Biotechnology Co (ROCO:6815) Total Long-Term Assets: NT$360.7 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6815 Diamond Biotechnology Co Ltd ROCO:6815
77 GF Score
Price NT$25.00
GF Value NT$41.70
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Diamond Biotechnology Co Total Long-Term Assets?

Diamond Biotechnology Co ROCO:6815 77 Total Long-Term Assets is NT$360.7 Mil as of Jun. 2026. GuruFocus rates ROCO:6815 with a GF Score™ of 77/100 and a GF Value™ of NT$41.70 (Possible Value Trap). The stock has 7 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Diamond Biotechnology Co's Total Long-Term Assets for the quarter that ended in Jun. 2026 was NT$360.7 Mil.

Diamond Biotechnology Co Total Long-Term Assets Related Terms

Diamond Biotechnology Co Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Diamond Biotechnology Co's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamond Biotechnology Co Total Long-Term Assets Chart

Diamond Biotechnology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only 185.45 261.24 401.48 366.92 369.41

Diamond Biotechnology Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 368.18 366.92 360.54 369.41 360.67
ROCO:6815
77GF Score
Diamond Biotechnology Co Ltd ROCO:6815
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diamond Biotechnology Co Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of NT$360.7 Mil mean?
Diamond Biotechnology Co (ROCO:6815) has a Total Long-Term Assets of NT$360.7 Mil as of Jun. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Diamond Biotechnology Co and its competitors.
Is Diamond Biotechnology Co's Total Long-Term Assets too high?
Diamond Biotechnology Co's current Total Long-Term Assets is NT$360.7 Mil. Overall, Diamond Biotechnology Co has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Diamond Biotechnology Co's Total Long-Term Assets compare to ABT and SYK?
Diamond Biotechnology Co's Total Long-Term Assets of NT$360.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Medical Devices & Instruments company?
A good Total Long-Term Assets depends on the Medical Devices & Instruments industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Diamond Biotechnology Co and its competitors. Diamond Biotechnology Co's current Total Long-Term Assets is NT$360.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diamond Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Diamond Biotechnology Co (ROCO:6815) is currently considered Possible Value Trap. The stock's GF Value™ is NT$41.70, compared to a current price of NT$25.00 — trading 40% below its estimated fair value. The current Total Long-Term Assets is NT$360.7 Mil. Diamond Biotechnology Co's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Diamond Biotechnology Co (ROCO:6815), the current Total Long-Term Assets is NT$360.7 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diamond Biotechnology Co (ROCO:6815) Overvalued in 2026?

Based on GuruFocus' analysis, Diamond Biotechnology Co stock appears to be undervalued. The current stock price of NT$25.00 is trading 40% below its estimated GF Value™ of NT$41.70. GuruFocus considers Diamond Biotechnology Co to be Possible Value Trap.

Key valuation signals for ROCO:6815:

  • Total Long-Term Assets: NT$360.7 Mil
  • GF Value™: NT$41.70 vs. price of NT$25.00 (40% below fair value)
  • GF Score™: 77/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6815 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diamond Biotechnology Co Business Description

Address No. 45, Section 2, Fuxing South Road, Da'an District, 11th Floor, Taipei, TWN
Diamond Biotechnology Co Ltd is engaged in the research and development of medical equipment, and medical consumables. It also manufactures and sells medical beauty-level skincare products.
77GF Score

Get the complete analysis for ROCO:6815

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$25.00
Price
NT$41.70
GF Value